

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.03968968 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.53088369 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.45585913 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.40663497 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.39553088 |
| 6 | vocalization behavior (GO:0071625) | 5.33499660 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.20289280 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.13304779 |
| 9 | glutamate secretion (GO:0014047) | 5.09278244 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.03499728 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.91119932 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.88297318 |
| 13 | protein localization to synapse (GO:0035418) | 4.67321715 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.61595062 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.55513348 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.47821614 |
| 17 | cerebellar granule cell differentiation (GO:0021707) | 4.46972034 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.43739858 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.41496465 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.40289543 |
| 21 | exploration behavior (GO:0035640) | 4.36123718 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.34522337 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.30888913 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.30139854 |
| 25 | * regulation of synaptic vesicle transport (GO:1902803) | 4.21928735 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.12584836 |
| 27 | regulation of ARF protein signal transduction (GO:0032012) | 4.11854160 |
| 28 | amino acid import (GO:0043090) | 3.91199978 |
| 29 | long-term memory (GO:0007616) | 3.89316445 |
| 30 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.85214931 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 3.83694568 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 3.81655422 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 3.80061360 |
| 34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.79373817 |
| 35 | proline transport (GO:0015824) | 3.75951943 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75195234 |
| 37 | potassium ion homeostasis (GO:0055075) | 3.69158873 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.68553976 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68247120 |
| 40 | neuron recognition (GO:0008038) | 3.64631821 |
| 41 | layer formation in cerebral cortex (GO:0021819) | 3.63863048 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.62541218 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.61180663 |
| 44 | long-term synaptic potentiation (GO:0060291) | 3.60535769 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.59226182 |
| 46 | * neurotransmitter transport (GO:0006836) | 3.58279790 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.52623586 |
| 48 | response to histamine (GO:0034776) | 3.49338886 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.48503159 |
| 50 | potassium ion import (GO:0010107) | 3.47443073 |
| 51 | * synaptic vesicle endocytosis (GO:0048488) | 3.46531932 |
| 52 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.42009275 |
| 53 | positive regulation of synapse maturation (GO:0090129) | 3.39524318 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.38555644 |
| 55 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.37850763 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.37469576 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.34898832 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.33724562 |
| 59 | sodium ion export (GO:0071436) | 3.33286460 |
| 60 | regulation of vesicle fusion (GO:0031338) | 3.33218171 |
| 61 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.31058376 |
| 62 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.30556412 |
| 63 | activation of protein kinase A activity (GO:0034199) | 3.29993237 |
| 64 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.26567978 |
| 65 | axonal fasciculation (GO:0007413) | 3.24934383 |
| 66 | neuromuscular process controlling posture (GO:0050884) | 3.21255133 |
| 67 | behavioral defense response (GO:0002209) | 3.21025000 |
| 68 | behavioral fear response (GO:0001662) | 3.21025000 |
| 69 | cellular sodium ion homeostasis (GO:0006883) | 3.20553393 |
| 70 | vesicle transport along microtubule (GO:0047496) | 3.20420598 |
| 71 | presynaptic membrane assembly (GO:0097105) | 3.18834797 |
| 72 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.18660177 |
| 73 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.17763156 |
| 74 | membrane depolarization (GO:0051899) | 3.17697586 |
| 75 | postsynaptic membrane organization (GO:0001941) | 3.14142579 |
| 76 | membrane depolarization during action potential (GO:0086010) | 3.13476095 |
| 77 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.12985837 |
| 78 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.12273807 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.11768446 |
| 80 | cell differentiation in hindbrain (GO:0021533) | 3.11484179 |
| 81 | neuromuscular process controlling balance (GO:0050885) | 3.11479949 |
| 82 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.09039955 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08639222 |
| 84 | startle response (GO:0001964) | 3.07773645 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.06866219 |
| 86 | regulation of exocytosis (GO:0017157) | 3.03852483 |
| 87 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.03710507 |
| 88 | fear response (GO:0042596) | 3.03504817 |
| 89 | innervation (GO:0060384) | 3.03210250 |
| 90 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.01621295 |
| 91 | membrane hyperpolarization (GO:0060081) | 2.99817263 |
| 92 | * learning (GO:0007612) | 2.99687377 |
| 93 | dendrite morphogenesis (GO:0048813) | 2.99378747 |
| 94 | * regulation of synaptic transmission (GO:0050804) | 2.98817510 |
| 95 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.98314932 |
| 96 | synaptic transmission (GO:0007268) | 2.98040011 |
| 97 | intraspecies interaction between organisms (GO:0051703) | 2.97121399 |
| 98 | social behavior (GO:0035176) | 2.97121399 |
| 99 | presynaptic membrane organization (GO:0097090) | 2.96767352 |
| 100 | response to auditory stimulus (GO:0010996) | 2.96508534 |
| 101 | detection of calcium ion (GO:0005513) | 2.95616275 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.95513680 |
| 103 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.95341185 |
| 104 | positive regulation of dendritic spine development (GO:0060999) | 2.93999695 |
| 105 | synapse assembly (GO:0007416) | 2.93859956 |
| 106 | L-amino acid import (GO:0043092) | 2.92354577 |
| 107 | central nervous system myelination (GO:0022010) | 2.92337548 |
| 108 | axon ensheathment in central nervous system (GO:0032291) | 2.92337548 |
| 109 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90524398 |
| 110 | * positive regulation of synaptic transmission (GO:0050806) | 2.89137618 |
| 111 | regulation of dendritic spine development (GO:0060998) | 2.88422300 |
| 112 | chemosensory behavior (GO:0007635) | 2.87839033 |
| 113 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.85473801 |
| 114 | adult walking behavior (GO:0007628) | 2.85275961 |
| 115 | neuronal ion channel clustering (GO:0045161) | 2.84987187 |
| 116 | cell communication by electrical coupling (GO:0010644) | 2.84246340 |
| 117 | mating behavior (GO:0007617) | 2.84191940 |
| 118 | regulation of synapse maturation (GO:0090128) | 2.83502730 |
| 119 | behavioral response to cocaine (GO:0048148) | 2.83444041 |
| 120 | * synaptic vesicle transport (GO:0048489) | 2.80398673 |
| 121 | * establishment of synaptic vesicle localization (GO:0097480) | 2.80398673 |
| 122 | negative regulation of neurotransmitter transport (GO:0051589) | 2.79106477 |
| 123 | clathrin coat assembly (GO:0048268) | 2.77836443 |
| 124 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75373885 |
| 125 | serotonin metabolic process (GO:0042428) | 2.73736391 |
| 126 | positive regulation of Rap GTPase activity (GO:0032854) | 2.72953647 |
| 127 | regulation of Rap GTPase activity (GO:0032317) | 2.71234266 |
| 128 | acidic amino acid transport (GO:0015800) | 2.67647955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.97095838 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.77096654 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.01942303 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91399049 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91132241 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64293309 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55642836 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50611642 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50611642 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41826905 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41725040 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41382930 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41081630 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39471559 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.38966659 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33132369 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.20938825 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18910179 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09369431 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09244561 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07527133 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03491902 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01822905 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91720328 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86542408 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.83006714 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82225222 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.81913491 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81068001 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75495331 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75000171 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74606523 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74004480 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68884594 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66055246 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60582889 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58040256 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55495697 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52467118 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52121810 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51701836 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41874969 |
| 43 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.37014434 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36557740 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36446023 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35948289 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35268912 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.35140389 |
| 49 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34365739 |
| 50 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.33064977 |
| 51 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.29438440 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29335632 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28937791 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26883708 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24911068 |
| 56 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24556520 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23515381 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22488064 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22152016 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.21772525 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20444356 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20011539 |
| 63 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19729360 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18591520 |
| 65 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17747824 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17269150 |
| 67 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15823047 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15634787 |
| 69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15285998 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15239804 |
| 71 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15130515 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14791921 |
| 73 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14576701 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13550437 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13073306 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11173310 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10638950 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09380683 |
| 79 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09262164 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09190103 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07790587 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06291148 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05188322 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05121906 |
| 85 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05052402 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04626895 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03674953 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03672431 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02646446 |
| 90 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01266071 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01216185 |
| 92 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00256901 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99853256 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99001942 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97811639 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97400578 |
| 97 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96901526 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96877144 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96664093 |
| 100 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95906960 |
| 101 | JUN_21703547_ChIP-Seq_K562_Human | 0.95466977 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.95143518 |
| 103 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94896644 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94673918 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94614955 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94614955 |
| 107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94327369 |
| 108 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93959009 |
| 109 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93449792 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92942920 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92590145 |
| 112 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.92583675 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92304344 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91808486 |
| 115 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91487480 |
| 116 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91097937 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90799406 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90415448 |
| 119 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90257747 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.90195150 |
| 121 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89483387 |
| 122 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.89471434 |
| 123 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89139825 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88512324 |
| 125 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87331126 |
| 126 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.86176395 |
| 127 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85777931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.61733948 |
| 2 | MP0003880_abnormal_central_pattern | 5.14263168 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.20481263 |
| 4 | MP0004270_analgesia | 3.60176644 |
| 5 | MP0009745_abnormal_behavioral_response | 3.52265507 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.40552468 |
| 7 | * MP0002064_seizures | 3.28341856 |
| 8 | MP0009046_muscle_twitch | 3.25099353 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.05285263 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.92683947 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.68098822 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.66973025 |
| 13 | MP0002272_abnormal_nervous_system | 2.65995575 |
| 14 | MP0002822_catalepsy | 2.62905401 |
| 15 | MP0001486_abnormal_startle_reflex | 2.54772980 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.52553251 |
| 17 | MP0002736_abnormal_nociception_after | 2.42202811 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.38261943 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.27826243 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.04696836 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.04277608 |
| 22 | MP0001970_abnormal_pain_threshold | 1.95929807 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.83864046 |
| 24 | MP0005386_behavior/neurological_phenoty | 1.83620974 |
| 25 | MP0004924_abnormal_behavior | 1.83620974 |
| 26 | MP0008569_lethality_at_weaning | 1.79493684 |
| 27 | MP0003329_amyloid_beta_deposits | 1.79216594 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.79003839 |
| 29 | MP0002184_abnormal_innervation | 1.73767754 |
| 30 | MP0003787_abnormal_imprinting | 1.73311243 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.72688617 |
| 32 | MP0004858_abnormal_nervous_system | 1.71840327 |
| 33 | MP0000778_abnormal_nervous_system | 1.71119313 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.70609538 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.69477431 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.65027499 |
| 37 | MP0003879_abnormal_hair_cell | 1.52172892 |
| 38 | MP0001984_abnormal_olfaction | 1.51477861 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.49114987 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.45889686 |
| 41 | MP0000955_abnormal_spinal_cord | 1.42880274 |
| 42 | MP0004885_abnormal_endolymph | 1.42510268 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.40431069 |
| 44 | * MP0002066_abnormal_motor_capabilities/c | 1.39771395 |
| 45 | MP0003633_abnormal_nervous_system | 1.38967461 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.35501553 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.33212784 |
| 48 | MP0001905_abnormal_dopamine_level | 1.31983185 |
| 49 | MP0001529_abnormal_vocalization | 1.31066767 |
| 50 | MP0003122_maternal_imprinting | 1.29290618 |
| 51 | MP0004142_abnormal_muscle_tone | 1.27757357 |
| 52 | MP0001188_hyperpigmentation | 1.23944323 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.20160171 |
| 54 | MP0003631_nervous_system_phenotype | 1.15986759 |
| 55 | MP0002229_neurodegeneration | 1.09511850 |
| 56 | MP0004510_myositis | 1.04584256 |
| 57 | MP0002152_abnormal_brain_morphology | 1.02776910 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.00094884 |
| 59 | MP0008872_abnormal_physiological_respon | 0.99033920 |
| 60 | MP0005535_abnormal_body_temperature | 0.96676223 |
| 61 | MP0008874_decreased_physiological_sensi | 0.95990289 |
| 62 | MP0004742_abnormal_vestibular_system | 0.95740190 |
| 63 | MP0000604_amyloidosis | 0.94973614 |
| 64 | MP0003690_abnormal_glial_cell | 0.94319634 |
| 65 | MP0001986_abnormal_taste_sensitivity | 0.94113897 |
| 66 | MP0002069_abnormal_eating/drinking_beha | 0.91325581 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.90228143 |
| 68 | MP0003075_altered_response_to | 0.89913364 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 0.89344047 |
| 70 | MP0003634_abnormal_glial_cell | 0.87733687 |
| 71 | MP0003303_peritoneal_inflammation | 0.87208490 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.84243586 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.82217260 |
| 74 | MP0003123_paternal_imprinting | 0.81844765 |
| 75 | MP0001177_atelectasis | 0.81659274 |
| 76 | MP0000920_abnormal_myelination | 0.80312018 |
| 77 | MP0000751_myopathy | 0.79975081 |
| 78 | MP0003632_abnormal_nervous_system | 0.79651752 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.78416202 |
| 80 | MP0002090_abnormal_vision | 0.78230827 |
| 81 | MP0004130_abnormal_muscle_cell | 0.76717319 |
| 82 | MP0004085_abnormal_heartbeat | 0.76486193 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.74982348 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.74569184 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.74475985 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.73338615 |
| 87 | MP0005499_abnormal_olfactory_system | 0.73338615 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.72489473 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.72388682 |
| 90 | MP0008260_abnormal_autophagy | 0.72361093 |
| 91 | MP0003121_genomic_imprinting | 0.71112441 |
| 92 | MP0004484_altered_response_of | 0.70273703 |
| 93 | MP0003724_increased_susceptibility_to | 0.69363608 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.68693518 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.68143210 |
| 96 | MP0004147_increased_porphyrin_level | 0.67377635 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.66538218 |
| 98 | MP0005409_darkened_coat_color | 0.66170715 |
| 99 | MP0003045_fibrosis | 0.65094248 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.64404281 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.63756991 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.58060065 |
| 103 | MP0001664_abnormal_digestion | 0.57447626 |
| 104 | MP0005166_decreased_susceptibility_to | 0.55575046 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.50819977 |
| 106 | MP0005253_abnormal_eye_physiology | 0.50020380 |
| 107 | MP0001943_abnormal_respiration | 0.49891529 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.49581846 |
| 109 | MP0003283_abnormal_digestive_organ | 0.49103085 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.47978072 |
| 111 | * MP0010769_abnormal_survival | 0.47266864 |
| 112 | MP0003956_abnormal_body_size | 0.46825097 |
| 113 | MP0004043_abnormal_pH_regulation | 0.46174006 |
| 114 | * MP0010770_preweaning_lethality | 0.46026575 |
| 115 | * MP0002082_postnatal_lethality | 0.46026575 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.45795655 |
| 117 | * MP0010768_mortality/aging | 0.45405057 |
| 118 | MP0005388_respiratory_system_phenotype | 0.44905621 |
| 119 | MP0002133_abnormal_respiratory_system | 0.44905621 |
| 120 | MP0002083_premature_death | 0.44388447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.07859192 |
| 2 | Myokymia (HP:0002411) | 6.40205856 |
| 3 | Focal seizures (HP:0007359) | 5.97971276 |
| 4 | Visual hallucinations (HP:0002367) | 5.36500464 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.21764423 |
| 6 | Febrile seizures (HP:0002373) | 4.94889801 |
| 7 | Atonic seizures (HP:0010819) | 4.91968597 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.57619356 |
| 9 | Absence seizures (HP:0002121) | 4.47157710 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.15607440 |
| 11 | Dialeptic seizures (HP:0011146) | 4.11723430 |
| 12 | Action tremor (HP:0002345) | 3.78048048 |
| 13 | Broad-based gait (HP:0002136) | 3.73957217 |
| 14 | Hyperventilation (HP:0002883) | 3.72073580 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.46035275 |
| 16 | Poor eye contact (HP:0000817) | 3.44850294 |
| 17 | Dysmetria (HP:0001310) | 3.22321997 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.20477627 |
| 19 | Truncal ataxia (HP:0002078) | 3.19173539 |
| 20 | Impaired social interactions (HP:0000735) | 3.18514243 |
| 21 | Abnormal social behavior (HP:0012433) | 3.18514243 |
| 22 | Depression (HP:0000716) | 3.16520948 |
| 23 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.15366274 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.13611163 |
| 25 | Papilledema (HP:0001085) | 3.12898808 |
| 26 | Excessive salivation (HP:0003781) | 3.08157934 |
| 27 | Drooling (HP:0002307) | 3.08157934 |
| 28 | Mutism (HP:0002300) | 3.03813622 |
| 29 | Ankle clonus (HP:0011448) | 3.01548590 |
| 30 | Tetraplegia (HP:0002445) | 2.99628865 |
| 31 | Anxiety (HP:0000739) | 2.97079339 |
| 32 | Genetic anticipation (HP:0003743) | 2.96950735 |
| 33 | * Supranuclear gaze palsy (HP:0000605) | 2.96692642 |
| 34 | Amblyopia (HP:0000646) | 2.95683667 |
| 35 | Progressive inability to walk (HP:0002505) | 2.93470423 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.93346703 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.86108248 |
| 38 | Diplopia (HP:0000651) | 2.86108248 |
| 39 | Impaired smooth pursuit (HP:0007772) | 2.84116520 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.82505557 |
| 41 | Apathy (HP:0000741) | 2.79699777 |
| 42 | Neurofibrillary tangles (HP:0002185) | 2.76419295 |
| 43 | Peripheral hypomyelination (HP:0007182) | 2.72872696 |
| 44 | Absent speech (HP:0001344) | 2.71395635 |
| 45 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.70125069 |
| 46 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.66801808 |
| 47 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.66801808 |
| 48 | Hemiparesis (HP:0001269) | 2.66033216 |
| 49 | Akinesia (HP:0002304) | 2.62970480 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.59662290 |
| 51 | Diminished motivation (HP:0000745) | 2.58916902 |
| 52 | Epileptiform EEG discharges (HP:0011182) | 2.49529146 |
| 53 | Spastic gait (HP:0002064) | 2.49402471 |
| 54 | * Postural instability (HP:0002172) | 2.49019579 |
| 55 | Urinary urgency (HP:0000012) | 2.47978621 |
| 56 | Scanning speech (HP:0002168) | 2.47926966 |
| 57 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.44853616 |
| 58 | Stereotypic behavior (HP:0000733) | 2.43547475 |
| 59 | Annular pancreas (HP:0001734) | 2.42926331 |
| 60 | * Rigidity (HP:0002063) | 2.40642027 |
| 61 | Clonus (HP:0002169) | 2.34036781 |
| 62 | Hemiplegia (HP:0002301) | 2.33761659 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.31436877 |
| 64 | Inability to walk (HP:0002540) | 2.31380950 |
| 65 | Limb dystonia (HP:0002451) | 2.30502114 |
| 66 | Status epilepticus (HP:0002133) | 2.29656931 |
| 67 | Polyphagia (HP:0002591) | 2.27723270 |
| 68 | Insidious onset (HP:0003587) | 2.27341586 |
| 69 | Termporal pattern (HP:0011008) | 2.27341586 |
| 70 | Generalized myoclonic seizures (HP:0002123) | 2.27189660 |
| 71 | Intention tremor (HP:0002080) | 2.25915449 |
| 72 | * Bradykinesia (HP:0002067) | 2.25854273 |
| 73 | Dysmetric saccades (HP:0000641) | 2.24601827 |
| 74 | Pheochromocytoma (HP:0002666) | 2.23517888 |
| 75 | Blue irides (HP:0000635) | 2.22973024 |
| 76 | Protruding tongue (HP:0010808) | 2.22115118 |
| 77 | Torticollis (HP:0000473) | 2.21570623 |
| 78 | Abnormality of the corticospinal tract (HP:0002492) | 2.20289171 |
| 79 | Abnormality of the lower motor neuron (HP:0002366) | 2.18672926 |
| 80 | Impaired vibratory sensation (HP:0002495) | 2.16309713 |
| 81 | Lower limb muscle weakness (HP:0007340) | 2.15705626 |
| 82 | Abnormality of salivation (HP:0100755) | 2.15589368 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.14938642 |
| 84 | Fetal akinesia sequence (HP:0001989) | 2.14919559 |
| 85 | Inappropriate behavior (HP:0000719) | 2.13421508 |
| 86 | Psychosis (HP:0000709) | 2.11112773 |
| 87 | Spastic tetraparesis (HP:0001285) | 2.07568376 |
| 88 | Memory impairment (HP:0002354) | 2.07544586 |
| 89 | Focal dystonia (HP:0004373) | 2.07213669 |
| 90 | Papillary thyroid carcinoma (HP:0002895) | 2.06298161 |
| 91 | Agitation (HP:0000713) | 2.05801625 |
| 92 | Cerebral hypomyelination (HP:0006808) | 2.03741734 |
| 93 | Increased circulating renin level (HP:0000848) | 2.03162639 |
| 94 | Gait ataxia (HP:0002066) | 2.01340004 |
| 95 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.01089941 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 2.00832614 |
| 97 | Ocular albinism (HP:0001107) | 1.97434457 |
| 98 | Bundle branch block (HP:0011710) | 1.94722996 |
| 99 | Ventricular fibrillation (HP:0001663) | 1.94698653 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 1.94215641 |
| 101 | Abnormality of saccadic eye movements (HP:0000570) | 1.91416751 |
| 102 | Gait imbalance (HP:0002141) | 1.90295741 |
| 103 | Thickened helices (HP:0000391) | 1.89618855 |
| 104 | Widely spaced teeth (HP:0000687) | 1.89434594 |
| 105 | Sleep apnea (HP:0010535) | 1.88887218 |
| 106 | Iris hypopigmentation (HP:0007730) | 1.87135726 |
| 107 | Decreased motor nerve conduction velocity (HP:0003431) | 1.86845047 |
| 108 | Generalized hypopigmentation of hair (HP:0011358) | 1.85551772 |
| 109 | Incomplete penetrance (HP:0003829) | 1.85530972 |
| 110 | Postural tremor (HP:0002174) | 1.84087257 |
| 111 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81380769 |
| 112 | Lower limb amyotrophy (HP:0007210) | 1.81109687 |
| 113 | Rapidly progressive (HP:0003678) | 1.78154196 |
| 114 | Obstructive sleep apnea (HP:0002870) | 1.78093465 |
| 115 | Failure to thrive in infancy (HP:0001531) | 1.76893890 |
| 116 | Craniofacial dystonia (HP:0012179) | 1.76662032 |
| 117 | Specific learning disability (HP:0001328) | 1.73983868 |
| 118 | Hypoventilation (HP:0002791) | 1.73224572 |
| 119 | Abnormal hair whorl (HP:0010721) | 1.71942620 |
| 120 | Amyotrophic lateral sclerosis (HP:0007354) | 1.70897792 |
| 121 | Delusions (HP:0000746) | 1.70747316 |
| 122 | Clumsiness (HP:0002312) | 1.70336814 |
| 123 | Abnormal EKG (HP:0003115) | 1.70192952 |
| 124 | Aqueductal stenosis (HP:0002410) | 1.70032192 |
| 125 | Megalencephaly (HP:0001355) | 1.69371944 |
| 126 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.68586145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.01810297 |
| 2 | EPHA4 | 4.18147662 |
| 3 | MAP3K9 | 3.80706748 |
| 4 | MAP3K4 | 3.19890855 |
| 5 | RIPK4 | 2.90208863 |
| 6 | MAP2K7 | 2.74139073 |
| 7 | MINK1 | 2.59628735 |
| 8 | MARK1 | 2.58670742 |
| 9 | MAP3K12 | 2.31752706 |
| 10 | DAPK2 | 2.19794091 |
| 11 | KSR2 | 2.06498331 |
| 12 | CASK | 2.03347793 |
| 13 | PAK6 | 2.02962521 |
| 14 | MAP2K4 | 1.99794887 |
| 15 | NTRK2 | 1.92845741 |
| 16 | PLK2 | 1.72792335 |
| 17 | PNCK | 1.70226536 |
| 18 | NTRK1 | 1.66627363 |
| 19 | MAP3K13 | 1.65118928 |
| 20 | TNIK | 1.59841497 |
| 21 | ARAF | 1.58924321 |
| 22 | CAMKK1 | 1.58039801 |
| 23 | PRKD3 | 1.56682695 |
| 24 | KSR1 | 1.54668639 |
| 25 | DAPK1 | 1.50112506 |
| 26 | CDK5 | 1.49180622 |
| 27 | GRK5 | 1.48223497 |
| 28 | FES | 1.46285993 |
| 29 | SIK2 | 1.44378163 |
| 30 | STK38 | 1.35766955 |
| 31 | BMPR2 | 1.30191441 |
| 32 | PRPF4B | 1.26110586 |
| 33 | CDK19 | 1.22163211 |
| 34 | PRKCG | 1.17634765 |
| 35 | MAPK13 | 1.15249537 |
| 36 | CAMK2A | 1.12708779 |
| 37 | RIPK1 | 1.12114607 |
| 38 | MAP3K2 | 1.09295711 |
| 39 | CAMKK2 | 1.07856321 |
| 40 | MAP3K11 | 0.95644928 |
| 41 | PTK2B | 0.95482840 |
| 42 | SGK223 | 0.93939905 |
| 43 | SGK494 | 0.93939905 |
| 44 | MAPK12 | 0.92413909 |
| 45 | RAF1 | 0.92295848 |
| 46 | SGK2 | 0.91272872 |
| 47 | CAMK2B | 0.90759284 |
| 48 | CAMK1 | 0.90381054 |
| 49 | UHMK1 | 0.89623618 |
| 50 | CAMK1D | 0.85511050 |
| 51 | STK11 | 0.85179430 |
| 52 | SGK1 | 0.82653628 |
| 53 | TYRO3 | 0.78763861 |
| 54 | SGK3 | 0.78282434 |
| 55 | CDK18 | 0.76848206 |
| 56 | RET | 0.76049479 |
| 57 | OXSR1 | 0.74599557 |
| 58 | CDK14 | 0.74435556 |
| 59 | CDK15 | 0.74311123 |
| 60 | PRKCH | 0.74282326 |
| 61 | CAMK1G | 0.73144526 |
| 62 | FGR | 0.72084279 |
| 63 | LATS2 | 0.71929824 |
| 64 | TAOK1 | 0.71247652 |
| 65 | JAK2 | 0.69539992 |
| 66 | PDK1 | 0.69208664 |
| 67 | DYRK1A | 0.69081899 |
| 68 | PHKG2 | 0.69064160 |
| 69 | PHKG1 | 0.69064160 |
| 70 | JAK1 | 0.68639263 |
| 71 | PINK1 | 0.66313181 |
| 72 | PAK3 | 0.65508192 |
| 73 | CDK12 | 0.64976422 |
| 74 | MAP3K1 | 0.64524961 |
| 75 | CSNK1G2 | 0.63628889 |
| 76 | CDK11A | 0.63223273 |
| 77 | TNK2 | 0.62971520 |
| 78 | MARK2 | 0.62407489 |
| 79 | PDPK1 | 0.61585792 |
| 80 | NME1 | 0.60804645 |
| 81 | PRKCE | 0.57592329 |
| 82 | CAMK2D | 0.54450841 |
| 83 | AKT3 | 0.49879483 |
| 84 | WNK1 | 0.49711675 |
| 85 | BRD4 | 0.48993672 |
| 86 | MAP3K5 | 0.48971656 |
| 87 | RPS6KA3 | 0.48971094 |
| 88 | CAMK2G | 0.48869878 |
| 89 | YES1 | 0.47549260 |
| 90 | BLK | 0.47508108 |
| 91 | MAP3K6 | 0.46836901 |
| 92 | SIK3 | 0.46391018 |
| 93 | PRKCZ | 0.46182742 |
| 94 | FYN | 0.46002396 |
| 95 | MAPK10 | 0.45972522 |
| 96 | ALK | 0.45698405 |
| 97 | LMTK2 | 0.45296328 |
| 98 | GRK7 | 0.43938144 |
| 99 | MOS | 0.43339627 |
| 100 | NEK6 | 0.41386635 |
| 101 | IRAK2 | 0.38730579 |
| 102 | CAMK4 | 0.38133338 |
| 103 | CDC42BPA | 0.37769793 |
| 104 | MAP3K7 | 0.36838015 |
| 105 | SYK | 0.36151830 |
| 106 | BRAF | 0.35184033 |
| 107 | DMPK | 0.34724511 |
| 108 | FER | 0.33849130 |
| 109 | WNK3 | 0.33541634 |
| 110 | PRKCB | 0.33206476 |
| 111 | MAP2K1 | 0.32252894 |
| 112 | SCYL2 | 0.31456922 |
| 113 | MAPKAPK5 | 0.31305867 |
| 114 | PRKG1 | 0.30668695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.82285876 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26549194 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.71087191 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.70849471 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65787292 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63881665 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63164721 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54403149 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.49772127 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46381002 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.16444300 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14505060 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12838798 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.95170983 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82487073 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82048802 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.79588373 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75412174 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.74679896 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.74677453 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74346456 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.70884781 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60498458 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.59302078 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57945092 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51013769 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42668721 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.35462094 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35397567 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34334053 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28920219 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26188386 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22741595 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.21418046 |
| 35 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15006867 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10974804 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08060380 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.06890218 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05834129 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03529031 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00637183 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00193362 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99478289 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 0.98615699 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98039764 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95901290 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92571309 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.92109584 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88799005 |
| 50 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85699562 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84221436 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81360468 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80003118 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78397040 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75503769 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74663687 |
| 57 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74416393 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74216680 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67857389 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67213582 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65361506 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63899174 |
| 63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63816073 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63706428 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62943104 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62311566 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58722214 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57745774 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57551532 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54728129 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.52454776 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50834546 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50425681 |
| 74 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50271200 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50064059 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49890913 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48880924 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48718541 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48173905 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48155292 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48033410 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47838502 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47480717 |
| 84 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46282441 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.45565487 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45555706 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.45362727 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44041893 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.43864083 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42836740 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42187938 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41017262 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40072714 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.39982572 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39882812 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39257635 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38976437 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38780281 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38686720 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37862367 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.36419858 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36213479 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35376273 |
| 104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34836320 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34674944 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34484943 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.34090686 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33350923 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33262192 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.30841758 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30736454 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.30350411 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30337853 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29416895 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28735035 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.28384297 |

